Disordered Polypeptide Hormone Expression

Prager, Diane

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Type: Research Project (R01)
• Project #: 5R01DK046484-04
• Application #: 2145712
• Study Section: General Medicine B Study Section (GMB)
• Project Start: 1993-04-01
• Project End: 1997-04-30
• Budget Start: 1996-06-01
• Budget End: 1997-04-30
• Support Year: 4
• Fiscal Year: 1996

Institution

• Name: Cedars-Sinai Medical Center
• DUNS #: 075307785
• City: Los Angeles
• State: CA
• Country: United States
• Zip Code: 90048

Publications

Mori, N; Prager, D (1997) Activation of the interleukin-10 gene in the human T lymphoma line HuT 78: identification and characterization of NF-kappa B binding sites in the regulatory region of the interleukin-10 gene. Eur J Haematol 59:162-70

Mori, N; Kashanchi, F; Prager, D (1997) Repression of transcription from the human T-cell leukemia virus type I long terminal repeat and cellular gene promoters by wild-type p53. Blood 90:4924-32

Mori, N; Gill, P S; Mougdil, T et al. (1996) Interleukin-10 gene expression in adult T-cell leukemia. Blood 88:1035-45

Mori, N; Prager, D (1996) Transactivation of the interleukin-1alpha promoter by human T-cell leukemia virus type I and type II Tax proteins. Blood 87:3410-7

Mori, N; Prager, D (1996) High levels of AP-2-binding activity in cell lines infected with human T-cell leukemia virus type I: possible enhancement of AP-2 binding by human T-cell leukemia virus type I tax. Cancer Res 56:779-82